Bank of America’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729 | Sell |
273
-5,151
| -95% | -$13.8K | ﹤0.01% | 6550 |
|
|
2025
Q1 | $43.6K | Buy |
5,424
+4,438
| +450% | +$35.6K | ﹤0.01% | 5777 |
|
|
2024
Q4 | $9.52K | Sell |
986
-63
| -6% | -$609 | ﹤0.01% | 6076 |
|
|
2024
Q3 | $19.5K | Buy |
1,049
+78
| +8% | +$1.45K | ﹤0.01% | 5840 |
|
|
2024
Q2 | $16.1K | Sell |
971
-1,002
| -51% | -$16.7K | ﹤0.01% | 5910 |
|
|
2024
Q1 | $34.2K | Sell |
1,973
-1,078
| -35% | -$18.7K | ﹤0.01% | 5751 |
|
|
2023
Q4 | $47.6K | Buy |
3,051
+1,155
| +61% | +$18K | ﹤0.01% | 5679 |
|
|
2023
Q3 | $93.7K | Buy |
1,896
+707
| +59% | +$35K | ﹤0.01% | 5394 |
|
|
2023
Q2 | $93K | Sell |
1,189
-25
| -2% | -$1.96K | ﹤0.01% | 5386 |
|
|
2023
Q1 | $110K | Sell |
1,214
-91
| -7% | -$8.25K | ﹤0.01% | 5428 |
|
|
2022
Q4 | $154K | Buy |
1,305
+693
| +113% | +$81.8K | ﹤0.01% | 5312 |
|
|
2022
Q3 | $111K | Sell |
612
-287
| -32% | -$52.1K | ﹤0.01% | 5480 |
|
|
2022
Q2 | $81K | Sell |
899
-117
| -12% | -$10.5K | ﹤0.01% | 5796 |
|
|
2022
Q1 | $158K | Sell |
1,016
-3,779
| -79% | -$588K | ﹤0.01% | 5846 |
|
|
2021
Q4 | $1.43M | Buy |
4,795
+4,180
| +680% | +$1.24M | ﹤0.01% | 4220 |
|
|
2021
Q3 | $355K | Sell |
615
-100
| -14% | -$57.7K | ﹤0.01% | 5079 |
|
|
2021
Q2 | $325K | Sell |
715
-655
| -48% | -$298K | ﹤0.01% | 5007 |
|
|
2021
Q1 | $738K | Buy |
1,370
+1,248
| +1,023% | +$672K | ﹤0.01% | 4480 |
|
|
2020
Q4 | $108K | Buy |
122
+79
| +184% | +$69.9K | ﹤0.01% | 5213 |
|
|
2020
Q3 | $27K | Buy |
+43
| New | +$27K | ﹤0.01% | 5560 |
|